Page last updated: 2024-09-03

head activator peptide and Idiopathic Parkinson Disease

head activator peptide has been researched along with Idiopathic Parkinson Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Franke, I; Gelderblom, M; Glassmeier, G; Ignatov, A; Imai, Y; Rezgaoui, M; Schaller, HC; Süsens, U; Takahashi, R; Urny, J1

Other Studies

1 other study(ies) available for head activator peptide and Idiopathic Parkinson Disease

ArticleYear
The neuropeptide head activator is a high-affinity ligand for the orphan G-protein-coupled receptor GPR37.
    Journal of cell science, 2006, Feb-01, Volume: 119, Issue:Pt 3

    Topics: Animals; Calcium; Calcium Signaling; Calcium-Calmodulin-Dependent Protein Kinases; Cell Death; Chlorocebus aethiops; COS Cells; Humans; Mitogens; Neuropeptides; Oocytes; Parkinson Disease; Phosphatidylinositol 3-Kinases; Pyrrolidonecarboxylic Acid; Receptors, G-Protein-Coupled; Transfection; Xenopus laevis

2006